[1]
“Sustained Anti-VEGF Delivery via Hydrogel Implant Achieves Non-Inferior Visual and Anatomical Outcomes in Neovascular AMD: A 24-Month Randomized Controlled Trial”, sjo, vol. 8, no. 2, pp. 486–493, Jun. 2026, doi: 10.37275/sjo.v8i2.138.